{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:04:04Z","timestamp":1756461844929,"version":"3.44.0"},"reference-count":10,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>The treatment of measles pneumonitis in immunocompromised adults is not established. We describe a patient with Hodgkin's lymphoma who developed acute pneumonia during a measles infection. On day 13, intravenous ribavirin and immunoglobulins were administrated. On day 18, the patient developed acute respiratory failure. An examination of transbronchial pulmonary biopsies showed Warthin-Finkeldey giant cells that are pathognomonic of measles pneumonitis. The patient died despite aggressive supportive care. Our case and a review of literature show that measles pneumonitis is routinely fatal in patients with cancer. We suggest that antiviral drugs should be considered as soon as the diagnosis has been established.<\/jats:p>","DOI":"10.1136\/bcr-2013-200252","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T08:38:06Z","timestamp":1381221486000},"page":"bcr2013200252","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Fatal measles pneumonitis during Hodgkin's lymphoma"],"prefix":"10.1136","volume":"2013","author":[{"given":"Benjamin","family":"Wyplosz","sequence":"first","affiliation":[{"name":"Assistance publique-h\u00f4pitaux de Paris, CHU Bic\u00eatre, Service de Maladies Infectieuses et Tropicales, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Lafarge","sequence":"additional","affiliation":[{"name":"Assistance publique-h\u00f4pitaux de Paris, CHU Bichat-Claude Bernard, R\u00e9animation M\u00e9dicale, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9lia","family":"Escaut","sequence":"additional","affiliation":[{"name":"Assistance publique-h\u00f4pitaux de Paris, CHU Bic\u00eatre, Service de Maladies Infectieuses et Tropicales, Le Kremlin-Bic\u00eatre, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Stern","sequence":"additional","affiliation":[{"name":"Assistance publique-h\u00f4pitaux de Paris, CHU Bic\u00eatre, Service de Maladies Infectieuses et Tropicales, Le Kremlin-Bic\u00eatre, France"},{"name":"Institut mutualiste Montsouris, Departement Thoracique, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,10,8]]},"reference":[{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.1","unstructured":"European Center for Disease Control. Epidemiological update on measles in EU and EEA\/EFTA Member States. Measles\u2014surveillance data. 2013. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/measles-rubella-monitoring-may-2013.pdf"},{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.2","unstructured":"European Center for Disease Control. Communicable disease threats report , 2013. Week 27, 30 Jun\u20136 July 2013. http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/Communicable-disease-threats-report-05-jul-2013.pdf"},{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3201\/eid1903.121360","article-title":"Measles elimination efforts and 2008\u20132011 outbreak, France","volume":"2013","author":"Antona","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1992.03480090085032","article-title":"Severe measles in immunocompromised patients","volume":"2013","author":"Kaplan","year":"1992","journal-title":"JAMA"},{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/CVI.13.4.437-443.2006","article-title":"Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals","volume":"2013","author":"Permar","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/clinids\/19.3.454","article-title":"Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin","volume":"2013","author":"Forni","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.7","first-page":"901","article-title":"[Fatal course of measles infection in a patient with a low-grade malignant non-Hodgkin lymphoma]","volume":"2013","author":"Klimkiewicz","year":"1998","journal-title":"Dtsch Med Wochenschr"},{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9343(90)90162-7","article-title":"Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy","volume":"2013","author":"Ross","year":"1990","journal-title":"Am J Med"},{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jviromet.2008.01.032","article-title":"A multiplex TaqMan PCR assay for the detection of measles and rubella virus","volume":"2013","author":"Hubschen","year":"2008","journal-title":"J Virol Methods"},{"key":"2025082723074505000_2013.oct08_1.bcr2013200252.10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2005.10.006","article-title":"Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens","volume":"2013","author":"Hummel","year":"2006","journal-title":"J Virol Methods"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-200252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:07:54Z","timestamp":1756361274000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-200252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,8]]},"references-count":10,"alternative-id":["10.1136\/bcr-2013-200252"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-200252","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,10,8]]}}}